No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
214 |
4. Check minimum number of eventsNone |
214 |
5. Include endpointsNone |
214 |
6. Filter based on genotype QC (FinnGen only) |
214 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M31
- Name in latin
- Microangiopathia thrombotica
Similar endpoints
↥List of similar endpoints to
Thrombotic microangiopathy
based on the number of shared cases.
Similar with more cases:
- Other necrotizing vasculopathies
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1214 | 706 | 498 |
| Only index persons | 1034 | 606 | 428 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 56.61 | 55.13 | 58.60 |
| Only index persons | 55.82 | 54.53 | 57.64 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 214 | 126 | 88 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 53.33 | 50.64 | 57.17 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 202
- Matched controls
- 2019
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
206.3
161
*
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
101.9
89
*
L04AX01
ATC
azathioprine; systemic
71.6
97.7
110
33
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
31.7
86.9
125
98
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
57.0
52
*
L04AA06
ATC
mycophenolic acid; systemic
105.7
56.7
60
8
N08.5*M31.1
ICD-10 Finland
Glomerular disorders in thrombotic thrombocytopenic purpura
+∞
51.3
47
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.9
40.2
133
397
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
+∞
39.9
37
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
17.4
38.5
63
51
M05BA04
ATC
alendronic acid; oral
15.6
36.7
63
57
L01AA01
ATC
cyclophosphamide; systemic
217.6
36.0
36
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
15.2
33.6
58
52
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
+∞
33.2
31
*
WW400
NOMESCO Finland
Plasmaferesis
+∞
32.1
30
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
10.3
29.7
63
85
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
65.3
29.2
33
6
ZX120
NOMESCO Finland
Intravenous
9.3
27.9
63
94
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.0
25.5
137
598
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
12.3
24.7
46
47
H02AB06
ATC
prednisolone; systemic
4.9
24.2
146
701
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
25.1
23.0
32
15
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
24.1
22.1
31
15
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
12.0
21.9
41
42
TK800
NOMESCO Finland
Hemodialysis
38.6
21.7
27
8
UDH02
NOMESCO Finland
Rhinopharyngoscopy
9.5
21.4
46
61
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
+∞
21.2
20
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
34.3
21.2
27
9
H02AB07
ATC
prednisone; oral
5.9
21.0
66
153
TPH04
NOMESCO Finland
Cathetrisation of vein
4.7
19.6
80
246
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.9
19.5
60
134
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
11.9
19.4
36
36
P01BA02
ATC
hydroxychloroquine; oral
8.1
18.7
44
67
H02AB04
ATC
methylprednisolone; systemic
5.3
18.7
64
161
R50.9
ICD-10 Finland
Fever, unspecified
5.8
18.3
57
128
A11CC03
ATC
alfacalcidol; systemic
16.7
18.3
29
20
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
8.8
18.1
40
55
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
18.0
17
*
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
+∞
18.0
17
*
Z94.0
ICD-10 Finland
Kidney transplant status
28.6
17.3
23
9
1XC02
NOMESCO Finland
NA
69.5
17.1
19
*
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
16.9
16
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.6
16.7
37
51
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.1
16.6
79
273
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
15.8
15
*
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
15.8
15
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
18.0
15.7
24
15
Z49.1
ICD-10 Finland
Extracorporeal dialysis
41.6
15.7
19
5
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
10.3
15.6
31
35
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.1
14.7
37
62
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
7.3
14.7
36
58
M35.1
ICD-10 Finland
Other overlap syndromes
161.2
14.7
15
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
9.8
14.3
29
34
N18.0
ICD-10 Finland
End-stage renal disease
32.7
14.1
18
6
A12AA04
ATC
calcium carbonate; oral
17.8
13.8
21
13
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
80.8
13.8
15
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
80.8
13.8
15
*
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
+∞
13.7
13
*
GD1AD
NOMESCO Finland
Thorax CT examination
9.1
13.4
28
35
L04AD01
ATC
ciclosporin; systemic
18.3
13.3
20
12
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
30.7
13.2
17
6
127
Kela drug reimbursment
Transplant complication
18.9
12.8
19
11
ZX108
NOMESCO Finland
Inhalation
34.5
12.8
16
5
B03XA02
ATC
darbepoetin alfa; parenteral
26.3
12.7
17
7
DHA10
NOMESCO Finland
Biopsy of cavity of nose
26.3
12.7
17
7
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
12.6
12
*
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
12.6
12
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
+∞
12.6
12
*
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
+∞
12.6
12
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
24.7
11.8
16
7
V03AE02
ATC
sevelamer; oral
69.1
11.7
13
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
5.0
11.7
39
92
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
+∞
11.6
11
*
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
11.6
11
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.8
11.4
52
167
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.0
11.2
31
59
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.0
11.2
80
359
TGC00
NOMESCO Finland
Bronchial lavation
11.5
11.1
20
19
C08CA05
ATC
nifedipine; systemic
5.7
10.9
32
65
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.7
10.9
38
94
L04AA01
ATC
[U] ciclosporin; systemic
14.0
10.9
18
14
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
23.0
10.9
15
7
A41.9
ICD-10 Finland
Sepsis, unspecified
10.1
10.8
21
23
C03CA01
ATC
furosemide; systemic
3.0
10.8
78
350
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.3
10.5
41
114
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
7.2
10.4
25
39
R4110
NOMESCO Finland
Physiotherapy
3.0
10.2
73
324
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.1
10.2
41
117
B03XA01
ATC
erythropoietin; parenteral
42.3
10.1
12
*
C09AA02
ATC
enalapril; systemic
3.1
10.0
62
250
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.5
9.9
52
184
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
16.1
9.7
15
10
ZXA00
NOMESCO Finland
Right side
2.9
9.7
73
334
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
10.3
9.5
18
19
N08.5*M31.0
ICD-10 Finland
Glomerular disorders in Goodpasture's syndrome
+∞
9.4
9
*
N08.2*D59.3
ICD-10 Finland
Glomerular disorders in haemolytic-uraemic syndrome
+∞
9.4
9
*
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
9.4
9
*
D59.3
ICD-10 Finland
Haemolytic-uraemic syndrome
+∞
9.4
9
*
A02BC02
ATC
pantoprazole; systemic
2.6
9.4
142
957
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.7
9.3
21
30
M05BA07
ATC
risedronic acid; oral
9.8
9.2
18
20
RS221
NOMESCO Finland
NA
12.3
9.2
16
14
WX892
NOMESCO Finland
Monitored bed care
4.9
9.2
30
69
N18.8
ICD-10 Finland
Other chronic renal failure
6.9
9.1
22
35
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.3
9.0
18
21
WX002
NOMESCO Finland
Sedation and analgesia
3.0
8.9
56
226
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.1
8.9
55
218
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.2
8.8
34
93
J01MA12
ATC
levofloxacin; systemic
3.0
8.8
56
228
A02BC01
ATC
omeprazole; systemic
2.7
8.8
72
340
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.4
8.8
26
54
Z49.2
ICD-10 Finland
Other dialysis
52.3
8.8
10
*
A02BC03
ATC
lansoprazole; oral
2.7
8.8
76
371
TPH07
NOMESCO Finland
Cathetrisation of artery
4.1
8.7
34
94
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
10.7
8.7
16
16
H26.3
ICD-10 Finland
Drug-induced cataract
21.1
8.6
12
6
137
Kela drug reimbursment
Uraemia requiring dialysis
21.1
8.6
12
6
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
93.8
8.5
9
*
J01MA14
ATC
moxifloxacin; systemic
4.1
8.4
33
92
4466A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Thrombotic microangiopathy
+∞
8.4
8
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
8.4
8
*
M31.7
ICD-10 Finland
Microscopic polyangiitis
+∞
8.4
8
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.9
8.4
59
255
B07.9
ICD-10 Finland
Verruca simplex
7.4
8.3
19
28
XG410
NOMESCO Finland
Flow-volume spirometry
6.0
8.3
22
40
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.2
8.2
31
83
H04.10
ICD-10 Finland
Dry eye syndrome
3.8
8.2
35
105
J01FF01
ATC
clindamycin; systemic
2.6
8.2
73
359
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
10.7
8.2
15
15
B05DB
ATC
Hypertonic solutions
34.9
8.2
10
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
7.1
8.1
19
29
M35.3
ICD-10 Finland
Polymyalgia rheumatica
13.8
8.0
13
10
WX203
NOMESCO Finland
Infraclavicular plexus blockade
11.5
7.9
14
13
C08CA01
ATC
amlodipine; oral
2.4
7.7
85
468
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
12.5
7.7
13
11
UDM02
NOMESCO Finland
Sinoscopy
9.4
7.7
15
17
V03AE01
ATC
polystyrene sulfonate; oral
19.3
7.7
11
6
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
19.3
7.7
11
6
B05DA
ATC
Isotonic solutions
26.1
7.6
10
*
ZXA05
NOMESCO Finland
Left side
2.6
7.6
64
303
A07AA02
ATC
nystatin; oral
4.7
7.5
25
59
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.0
7.5
46
181
R04.0
ICD-10 Finland
Epistaxis
5.1
7.5
23
50
M05BB03
ATC
alendronic acid and colecalciferol; oral
8.9
7.5
15
18
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
7.4
71
363
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.8
7.4
31
92
C08CA02
ATC
felodipine; oral
3.8
7.4
31
92
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
+∞
7.3
7
*
N08.5*M30.0
ICD-10 Finland
Glomerular disorders in polyarteritis nodosa
+∞
7.3
7
*
J01MA02
ATC
ciprofloxacin; systemic
2.3
7.3
96
572
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.1
7.2
28
77
Z49.0
ICD-10 Finland
Preparatory care for dialysis
31.2
7.2
9
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
12.7
7.2
12
10
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
9.3
7.2
14
16
H65.3
ICD-10 Finland
Chronic mucoid otitis media
10.6
7.1
13
13
L88
ICPC
Rheumatoid/seropositive arthritis
6.8
7.1
17
27
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
6.8
68
352
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
41.5
6.8
8
*
M13.9
ICD-10 Finland
Arthritis, unspecified
4.4
6.7
23
57
C02CA01
ATC
prazosin; oral
10.5
6.6
12
12
H65.2
ICD-10 Finland
Chronic serous otitis media
14.9
6.5
10
7
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
14.9
6.5
10
7
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
72.0
6.5
7
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
72.0
6.5
7
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.9
6.4
25
70
N085, M318
ICD-10 Finland
NA
+∞
6.3
6
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
+∞
6.3
6
*
4464A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Wegener's granulomatosis
+∞
6.3
6
*
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
+∞
6.3
6
*
6BA02
NOMESCO Finland
NA
27.6
6.3
8
*
J05AB01
ATC
aciclovir; systemic
2.5
6.3
52
242
205
Kela drug reimbursment
Chronic hypertension
2.3
6.2
68
366
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
13.1
6.1
10
8
J01DA01
ATC
[U] cefalexin; systemic
2.1
6.0
136
995
J31.0
ICD-10 Finland
Chronic rhinitis
3.7
6.0
25
74
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
42
27
19.11
49.96
7.4
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
42
28
18.42
49.03
4.6
1.1
titre
346.7
—
—
15
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
40
26
18.69
47.23
7.3
7.4
iu/ml
609.4
139.8
—
10
5
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
54
65
10.77
43.61
9.4
1.9
g/l
1.4
1.4
0.16
49
54
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
44
41
13.25
42.28
4.2
1.2
iu/ml
10.4
—
—
9
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
85
201
6.36
37.00
6.6
2.3
%
25.2
23.1
0.48
74
173
(42870588) Differential panel, method unspecified - Blood
138
518
5.69
34.86
21.4
4.8
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
33
29
13.27
32.59
1.5
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
24
12
22.40
31.50
1.6
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
160
728
5.75
30.65
23.1
5.5
%
0.6
0.6
0.59
160
681
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
33
32
12.01
30.56
1.4
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
168
797
6.15
30.53
22.6
5.3
e9/l
0.0
0.0
0.17
163
698
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
28
21
15.19
30.25
1.4
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
169
824
6.00
29.16
22.7
5.3
e9/l
1.6
2.0
2.13
163
739
(3013115) Eosinophils [#/volume] in Blood
169
829
5.94
28.80
23.6
5.8
e9/l
0.2
0.2
0.57
164
745
(3006504) Eosinophils/100 leukocytes in Blood
160
752
5.47
28.74
23.4
5.5
%
2.5
2.7
0.58
160
707
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
38
10.45
28.50
6.2
2.3
u/ml
0.3
0.4
0.45
20
24
(3019069) Monocytes/100 leukocytes in Blood
160
756
5.42
28.44
23.9
5.8
%
9.5
8.4
3.49
160
713
(3018010) Neutrophils/100 leukocytes in Blood
160
769
5.28
27.46
22.2
5.4
%
61.4
57.8
3.50
160
720
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
29
28
11.82
26.82
1.6
1.3
u/ml
125.8
97.7
—
5
6
(3002030) Lymphocytes/100 leukocytes in Blood
160
781
5.16
26.58
23.7
5.6
%
23.9
27.9
5.17
160
730
(3023520) Reticulocytes [#/volume] in Blood
54
118
5.78
24.75
5.3
3.1
e9/l
80.2
68.4
0.94
39
97
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
147
716
4.36
23.36
23.1
6.2
mmol/l
1.2
1.2
0.10
141
653
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
135
621
4.18
23.25
12.9
3.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
57
138
5.27
23.19
6.3
4.8
%
0.9
0.9
0.04
26
42
(3018418) pH of Serum or Plasma
116
483
4.06
23.03
14.5
3.8
ph
7.4
7.4
0.27
19
80
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
27
10.82
22.80
1.5
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
172
962
5.01
22.02
25.8
8.9
e9/l
4.5
4.2
0.64
164
849
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
30
41
8.35
21.35
6.3
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
19
13
15.94
21.32
5.7
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
65
190
4.48
20.81
3.3
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
52
127
5.09
20.80
6.6
5.0
%
1.6
0.2
0.43
24
36
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
24
26
10.27
20.37
2.2
1.1
u/ml
7.2
5.3
0.19
12
13
(3017143) Hepatitis C virus Ab [Presence] in Serum
63
183
4.46
20.29
2.7
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
151
797
4.04
20.27
27.7
7.0
mmol/l
1.2
1.2
0.33
133
684
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
17
11
16.70
19.56
1.2
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
55
148
4.66
19.47
15.3
3.4
mmol/l
1.1
1.9
0.91
49
114
(3002179) Metamyelocytes/100 leukocytes in Blood
49
120
5.00
19.46
6.3
4.9
%
0.5
0.4
0.27
17
24
(3000991) Gas panel - Venous blood
50
125
4.91
19.37
25.6
8.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
63
193
4.21
18.78
2.1
1.3
titre
736.7
373.0
1.21
24
43
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
22
24
10.10
18.53
2.2
1.2
u/ml
3.0
1.3
—
10
7
(4268621)
19
17
12.17
18.24
3.2
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
15
13.01
18.03
1.2
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
107
479
3.47
17.96
10.6
2.8
—
—
—
0
0
(3012544) pH of Venous blood
54
152
4.41
17.95
16.3
3.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
46
114
4.87
17.93
1.8
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
108
488
3.45
17.83
10.1
3.1
mmol/l
6.8
7.7
1.77
102
417
(3018095) Leukocytes [#/volume] in Urine
125
619
3.45
17.74
13.0
3.5
e6/l
39.1
75.7
0.70
111
441
(3002582) Erythrocytes [#/volume] in Urine
115
542
3.42
17.69
11.4
3.0
e6/l
35.0
162.7
0.54
106
414
(3025159) Blasts/100 leukocytes in Blood
47
120
4.74
17.66
6.3
5.0
%
0.1
0.0
0.11
19
29
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
28
44
7.17
17.57
1.8
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
102
451
3.41
17.34
9.3
3.3
mg/l
155.9
62.3
1.40
87
301
(3023368) Bacteria identified in Blood by Culture
100
441
3.38
17.00
9.1
4.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
70
247
3.73
16.89
3.7
2.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
53
6.42
16.85
1.5
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
70
249
3.69
16.66
6.9
3.5
mmol/l
0.8
0.8
0.07
65
238
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
17
11.47
16.65
2.5
2.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
104
480
3.27
16.23
11.4
4.1
mg/mmol
34.6
9.8
1.79
86
311
(46235355) HIV 1 and 2 tests - Meaningful Use set
81
323
3.43
16.07
2.6
2.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
29
8.34
16.00
5.7
2.7
e9/l
4.8
4.6
0.13
22
29
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
26
42
6.91
15.87
1.5
1.4
iu/ml
0.7
0.1
—
5
7
(3024561) Albumin [Mass/volume] in Serum or Plasma
131
701
3.24
15.72
13.6
4.5
g/l
34.4
35.7
1.89
125
666
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
72
272
3.48
15.49
2.8
1.7
—
—
—
0
0
(3036489) Thrombin time
29
54
6.06
15.42
7.8
1.5
s
22.2
21.0
0.98
29
49
(3030467) Casts [#/volume] in Urine by Automated count
103
487
3.15
15.20
11.6
2.9
e6/l
0.2
0.3
0.38
95
361
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
31
7.80
15.12
6.0
3.3
%
62.7
58.3
0.59
22
31
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
54
173
3.84
14.84
2.5
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
71
281
3.28
14.00
8.5
2.6
e6/l
0.9
1.0
0.11
53
157
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
67
257
3.34
13.90
2.7
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
12
12.41
13.66
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
12
12.41
13.66
1.4
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
12
12.41
13.66
1.4
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
12
12.41
13.66
1.4
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
12
12.41
13.66
1.4
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
12
12.41
13.66
1.4
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
53
179
3.61
13.38
2.7
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
98
481
2.91
13.09
2.8
1.9
u/l
128.5
222.6
1.35
92
456
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
38
103
4.27
13.05
2.3
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
23
40
6.32
13.03
1.5
1.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
93
445
2.93
13.01
5.9
2.6
umol/l
369.9
8239.6
2.40
86
379
(4062490)
14
13
11.45
12.99
2.4
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
44
6.02
12.91
3.1
2.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
140
845
2.90
12.41
9.4
3.4
estimate
0.0
0.0
0.00
31
163
(3003396) Base excess in Arterial blood by calculation
52
184
3.41
12.13
14.0
9.7
mmol/l
0.8
1.2
0.35
39
143
(3011397) Hemoglobin [Presence] in Urine by Test strip
80
369
2.87
11.77
8.1
3.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
139
851
2.81
11.73
12.7
4.6
estimate
0.0
0.0
0.00
34
165
(3009261) Glucose [Presence] in Urine by Test strip
140
862
2.80
11.65
9.4
3.4
estimate
0.0
0.0
0.00
32
157
(3023419) Bacteria identified in Sputum by Culture
16
21
8.15
11.58
3.6
3.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
80
372
2.84
11.56
4.7
1.6
mg/l
1.8
0.9
2.86
70
300
(3037121) Protein [Mass/volume] in Urine
25
54
5.11
11.27
6.6
3.5
g/l
0.4
0.3
0.39
18
21
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
65
274
2.97
11.22
8.9
2.7
e6/l
1.6
2.8
0.59
46
152
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
34
95
4.07
11.16
10.3
3.8
mmol/l
0.9
1.6
0.42
22
73
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
19
8.41
11.15
1.1
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
18
29
6.69
10.92
13.9
3.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
16
23
7.44
10.72
14.1
1.8
%
74.3
64.9
0.89
16
23
(3052851) Hemolysis interference index of Serum or Plasma
22
45
5.33
10.51
3.3
2.6
—
—
—
0
0
(3009343) pH of Capillary blood
34
100
3.85
10.38
10.3
3.7
ph
7.4
7.4
—
6
12
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
38
5.70
10.33
2.0
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
51
198
3.07
10.08
2.2
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
82
410
2.62
10.05
10.2
3.4
%
99.1
91.5
1.55
82
403
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
13
9.72
9.96
2.2
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
29
6.28
9.75
6.4
2.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
26
6.57
9.60
1.9
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
85
441
2.54
9.56
17.8
6.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
23
6.94
9.48
2.0
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
167
1188
2.85
9.48
14.7
4.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
20
7.42
9.40
1.1
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
20
7.42
9.40
1.9
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
17
8.08
9.38
1.7
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
19
38
5.39
9.28
2.1
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
28
6.10
8.94
1.8
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
26
71
4.03
8.75
9.3
3.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
35
118
3.35
8.67
3.0
2.3
g/l
61.5
66.0
1.95
35
106
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
22
6.74
8.64
1.9
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
120
755
2.34
8.51
28.2
8.7
e9/l
0.0
0.0
0.21
111
617
(40760892) CBC W Ordered Manual Differential panel - Blood
73
372
2.46
8.36
13.0
5.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
13
9
15.27
8.31
2.3
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
19
42
4.87
8.30
7.5
2.4
kpa
8.5
8.4
0.04
19
36
(3013826) Glucose [Moles/volume] in Serum or Plasma
144
991
2.39
8.14
13.9
4.9
mmol/l
6.9
6.7
0.26
136
915
(3015377) Calcium [Moles/volume] in Serum or Plasma
96
558
2.31
8.10
5.0
3.2
mmol/l
2.4
2.3
0.23
85
498
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
18
39
4.95
8.04
3.7
4.1
—
3.8
—
0
6
(3044640) Blood type and Crossmatch panel - Blood
95
552
2.30
8.00
4.2
2.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
40
4.82
7.81
1.7
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
107
659
2.25
7.77
16.4
8.3
inr
1.1
1.3
3.35
30
217
(3005322) IgE [Units/volume] in Serum or Plasma
28
88
3.51
7.71
1.2
1.2
u/ml
45.5
385.9
0.69
23
80
(40760888) Immunoglobulin light chains.free panel - Serum
14
25
5.92
7.65
3.7
5.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
25
5.92
7.65
1.9
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
12
8.69
7.64
2.2
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
9
14.03
7.48
3.5
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
19
6.63
7.32
1.9
3.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
88
510
2.23
7.32
3.8
3.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
16
7.19
7.22
6.8
3.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
26
83
3.43
6.98
20.0
14.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
25
78
3.50
6.95
2.5
1.6
—
—
—
0
0
(4306422)
13
24
5.70
6.86
1.2
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
17
6.77
6.84
1.9
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
28
95
3.24
6.84
3.2
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
36
4.72
6.83
1.8
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
71
388
2.24
6.72
3.6
2.0
mg/l
3.1
3.0
0.14
63
341
(3007164) IgA [Mass/volume] in Serum or Plasma
65
346
2.26
6.53
2.2
1.4
g/l
1.6
2.5
3.85
52
211
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
18
6.39
6.49
1.9
1.6
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
10
7
14.90
6.46
1.8
1.4
umol/l
14.8
8.1
—
10
7
(40761535) Cells panel - Urine sediment
33
129
2.84
6.32
8.8
3.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
5
18.70
6.32
3.2
2.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
14
30
4.92
6.31
2.3
1.3
—
—
—
0
0
(4035726)
34
136
2.78
6.24
1.6
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
28
4.88
5.82
2.4
1.4
—
—
—
0
0
(44806118)
10
17
6.12
5.68
2.0
1.6
—
—
—
0
0
(44790047)
10
17
6.12
5.68
2.0
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
17
6.12
5.68
1.2
1.3
—
—
—
0
0
(44790049)
10
17
6.12
5.68
2.0
1.6
—
—
—
0
0
(44790048)
10
17
6.12
5.68
2.0
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
16
42
4.04
5.65
5.0
1.5
g/l
36.6
37.8
0.32
16
36
(1616796) Gas panel - Central venous blood
14
33
4.47
5.65
4.9
2.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
34
4.34
5.45
1.9
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
34
4.34
5.45
1.9
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
49
3.68
5.29
4.8
1.4
g/l
3.1
3.1
0.06
17
39
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
5
0
+∞
5.23
5.4
0.0
mg/l
4.8
—
—
5
0
(3019060) Gas panel - Arterial blood
28
112
2.73
5.12
4.3
8.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
6
13.78
5.12
1.1
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
23
4.99
5.07
1.6
2.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
56
3.42
5.02
4.6
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
58
326
2.07
4.93
4.1
3.9
ng/l
91.0
138.3
0.34
46
248
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
116
827
1.88
4.88
6.5
4.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
30
128
2.56
4.84
4.4
3.1
ml/min/173m2
56.1
68.5
0.88
16
54
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
10
9.33
4.83
1.9
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
67
400
1.98
4.81
4.4
2.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
8
10.33
4.56
1.5
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
8
10.33
4.56
1.5
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
37
179
2.29
4.55
5.1
3.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
30
4.18
4.50
1.2
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
12
30
4.18
4.50
3.3
2.2
%
16.5
15.9
—
7
16
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
9
9.18
4.31
2.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
9
9.18
4.31
2.0
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
12
32
3.91
4.14
3.8
2.4
mmol/l
2.1
2.9
—
6
20
(3028433) Virus identified in Specimen by Culture
7
7
10.28
4.04
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
38
3.58
3.97
1.2
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
49
3.22
3.89
1.6
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
71
460
1.81
3.86
11.3
3.7
estimate
0.0
0.0
0.00
31
159
(3045414) Leukocytes [Presence] in Urine
17
61
2.94
3.79
2.1
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
94
666
1.73
3.74
10.3
3.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
40
3.40
3.69
1.8
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
62
2.89
3.68
2.9
2.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
9
7.99
3.58
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
9
7.99
3.58
2.0
4.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
13
6.34
3.53
1.9
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
31
3.69
3.53
4.7
2.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
6
10.24
3.52
1.7
2.8
%
141.0
82.0
—
6
6
(3029075) Extractable nuclear Ab panel - Serum
6
6
10.24
3.52
1.2
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
13
42
3.23
3.43
11.5
3.0
mmol/l
22.0
24.6
1.41
13
33
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
42
3.23
3.43
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
73
492
1.73
3.41
8.8
3.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
10
7.19
3.39
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
14
5.89
3.37
1.8
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
21
90
2.48
3.37
2.5
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
7
8.77
3.28
2.7
2.7
u/ml
2119.8
978.7
—
6
7
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
33
3.46
3.24
2.3
1.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
7
11
6.53
3.21
1.3
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
89
643
1.66
3.17
2.1
1.9
pmol/l
93.1
96.4
0.29
52
335
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
16
5.15
3.08
1.1
1.5
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
6
8
7.67
3.07
1.5
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
8
7.67
3.07
5.7
2.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
38
611
0.54
3.00
4.6
2.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
5
10.19
2.99
1.4
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
86
624
1.63
2.97
5.2
3.6
ng/l
44.7
36.9
0.21
66
415
(40768804) Tissue Pathology biopsy report
94
698
1.62
2.96
2.6
2.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
58
380
1.72
2.95
1.5
1.4
nmol/l
16.9
20.4
1.46
51
320
(3021788) Differential panel - Synovial fluid
8
18
4.57
2.82
1.8
1.4
—
—
—
0
0
(3019225) pH of Specimen
27
140
2.06
2.80
14.1
4.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
16
66
2.54
2.78
1.2
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
10
6.14
2.71
5.8
2.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
49
315
1.72
2.65
2.7
2.8
mmol/l
2.5
2.4
1.22
44
277
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
25
3.71
2.60
1.4
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
7
7.28
2.56
2.2
2.6
%
103.2
98.4
—
5
7
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
11
5.58
2.56
1.0
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
11
5.58
2.56
1.5
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
160
0.30
2.54
1.4
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
16
4.48
2.49
1.6
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
19
90
2.22
2.47
2.3
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
34
3.04
2.44
1.5
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
12
5.11
2.42
1.0
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
23
119
2.05
2.41
11.0
3.8
mmol/l
1.2
1.2
0.25
23
101
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
8
6.37
2.38
1.8
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
17
4.22
2.38
4.3
4.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
53
2.55
2.32
1.3
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
13
4.71
2.28
10.0
1.9
%
10.2
11.3
—
6
13
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
13
4.71
2.28
1.3
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
18
3.98
2.27
1.3
1.3
%
85.1
90.5
—
7
18
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
18
3.98
2.27
7.1
3.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
24
3.42
2.20
1.9
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
55
2.45
2.16
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
10
5.09
2.08
1.4
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
19
97
2.05
2.07
1.7
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
11
4.63
1.95
3.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
11
4.63
1.95
3.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
11
4.63
1.95
2.4
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
16
3.83
1.95
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
52
2.39
1.91
1.3
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
43
292
1.59
1.87
1.7
1.7
nmol/l
1134.3
1201.5
0.22
38
230
(3044941) Cell count panel - Synovial fluid
6
17
3.60
1.85
3.8
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
12
4.24
1.83
1.6
1.4
ug/l
13.3
13.4
—
5
12
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
23
3.11
1.81
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
47
2.41
1.81
1.6
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
54
2.29
1.77
3.0
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
53
383
1.51
1.75
10.1
3.6
kg/l
1.0
1.0
—
6
52
(40761536) Microorganisms panel - Urine sediment
25
150
1.75
1.72
14.3
3.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
13
3.91
1.72
1.6
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
30
190
1.67
1.71
2.1
1.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
14
3.63
1.62
7.8
2.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
61
461
1.45
1.61
2.0
1.7
mmol/l
1.5
1.4
0.70
55
394
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
188
1743
1.65
1.59
49.0
13.0
mg/l
18.6
23.4
2.11
179
1360
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
20
3.06
1.59
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
64
2.10
1.57
2.2
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
15
3.39
1.53
1.8
1.9
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
15
3.39
1.53
1.8
1.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
15
3.39
1.53
1.8
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
15
3.39
1.53
1.8
1.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
65
2.06
1.52
2.3
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
16
3.17
1.44
1.8
1.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
16
3.17
1.44
1.8
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
16
3.17
1.44
2.2
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
17
2.99
1.36
1.2
1.2
—
—
—
0
0
(3000492) Spirometry study
22
138
1.66
1.32
2.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
63
1.96
1.25
1.2
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
25
2.44
1.25
1.3
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
39
2.09
1.16
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
39
288
1.43
1.16
1.7
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
20
127
1.63
1.16
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
31
2.30
1.11
2.4
1.9
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
5
21
2.41
1.09
1.2
1.1
mosm/kgh2o
281.2
279.1
—
5
16
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
21
2.41
1.09
1.2
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
133
1192
1.31
1.09
4.8
3.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
21
307
0.65
1.07
2.0
3.1
ug/l
0.8
0.7
0.13
15
203
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
152
1637
0.75
1.05
5.6
4.4
mmol/l
6.0
5.9
0.13
144
1503
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
21
139
1.57
1.05
3.5
2.4
ug/l
3.0
7.6
1.61
16
122
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
11
60
1.88
1.05
1.1
1.3
miu/ml
262.2
290.6
—
5
30
(3000330) Specific gravity of Urine by Test strip
14
83
1.73
1.04
9.7
3.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
34
2.09
1.04
1.1
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
48
376
1.36
1.02
1.3
1.3
u/ml
4.0
1.3
0.45
14
105
(3020891) Body temperature
11
64
1.76
0.88
5.5
4.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
57
1.79
0.85
1.5
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
32
1.90
0.82
3.2
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
168
1579
1.30
0.81
49.1
14.2
%
38.0
40.0
3.46
116
1182
(21494755) Public health laboratory ask at order entry panel
12
181
0.64
0.73
1.2
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
7
41
1.73
0.70
3.1
3.3
mmol/l
1.4
1.4
—
7
41
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
163
1714
0.79
0.69
6.5
4.7
mmol/l
2.6
2.7
1.67
156
1587
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
201
0.68
0.68
1.6
2.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
140
1302
1.22
0.67
3.9
4.1
pmol/l
14.7
14.8
0.19
134
1175
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
160
1681
0.81
0.63
6.2
4.3
mmol/l
4.6
4.6
0.41
153
1568
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
24
184
1.34
0.61
1.9
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
28
220
1.31
0.61
1.4
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
15
207
0.70
0.60
2.0
1.8
%
1.4
1.4
0.14
15
181
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
123
1140
1.19
0.57
3.8
3.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
181
0.70
0.55
1.2
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
35
420
0.80
0.54
3.2
4.4
%
24.8
20.9
0.88
18
199
(3038515) Glucose [Moles/volume] in Venous blood
6
40
1.51
0.52
3.5
3.3
mmol/l
7.9
7.5
—
6
40
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
160
1669
0.84
0.49
6.1
4.2
mmol/l
1.5
1.5
0.01
152
1546
(3022145) Colonoscopy Study observation
23
182
1.30
0.49
1.6
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
34
284
1.23
0.47
1.2
1.3
u/ml
3.4
13.0
—
8
116
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
69.3
—
0
5
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
35
1.44
0.39
1.6
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
165
1592
1.16
0.36
4.9
4.7
mu/l
2.0
2.6
0.37
155
1448
(3002256) Pathology report gross observation
25
209
1.22
0.36
1.6
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
43
1.41
0.35
1.0
1.1
—
3.4
—
0
7
(3011288) Drugs identified in Urine by Screen method
6
43
1.41
0.35
12.7
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
162
1563
1.15
0.35
8.2
5.6
mmol/mol
39.2
39.8
0.36
156
1468
(3003694) ABO and Rh group [Type] in Blood
56
507
1.14
0.33
1.9
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
111
1.28
0.31
5.3
2.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
156
1610
0.89
0.30
5.6
3.8
mmol/l
1.5
1.3
2.46
148
1491
(1761482) Bacteria [#/volume] in Urine by Culture
7
56
1.26
0.29
5.4
4.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
167
1623
1.13
0.28
38.0
12.4
ml/min/173m2
71.5
82.3
4.74
155
1334
(4010399)
14
114
1.24
0.26
1.2
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
14
114
1.24
0.26
1.2
1.3
—
29.0
—
0
7
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
76
1.19
0.25
2.0
2.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
77
1.18
0.24
1.0
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
22
190
1.18
0.24
4.6
4.4
%
30.5
32.3
0.45
17
127
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
93
0.74
0.23
1.6
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
19.6
—
994.4
—
0
14
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
14
0.00
0.20
0.0
2.7
—
13.6
—
0
14
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
28.8
—
1940.1
—
0
14
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
53
1.14
0.19
1.7
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
181
1839
0.90
0.18
37.0
12.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
63
1.11
0.17
1.7
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
68
1.18
0.17
5.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
120
1.18
0.17
1.6
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
72
1.12
0.16
5.0
1.4
—
—
—
0
0
(1002224) Polysomnography panel
6
76
0.78
0.16
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
73
1.10
0.16
1.8
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
73
1.10
0.16
5.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
73
1.10
0.16
3.5
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
73
1.10
0.16
5.0
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
77
0.77
0.16
1.2
1.1
—
—
—
0
0
(3013512) EKG study
51
486
1.06
0.11
5.6
3.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
106
1.14
0.10
1.9
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
44
1.14
0.10
4.4
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
20
184
1.10
0.09
13.8
7.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
54
1.11
0.09
1.0
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
57
1.05
0.08
6.3
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
5
61
0.82
0.08
2.8
1.4
mu/l
338.8
321.1
—
5
56
(4034850)
5
60
0.83
0.08
18.2
10.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
51
528
0.96
0.07
3.5
4.9
ug/l
1.9
2.6
0.56
45
472
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
31
296
1.06
0.06
1.2
1.2
iu/ml
41.4
37.5
—
9
89
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
220
0.95
0.03
1.4
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
33
334
0.99
0.00
1.5
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
17
165
1.03
0.00
1.8
4.3
ug/l
2.5
78.6
0.92
12
135
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
60
1.00
0.00
1.5
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
60
1.00
0.00
1.5
1.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
19.6
—
0
5
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
60
1.00
0.00
1.5
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
60
1.00
0.00
1.5
1.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
6
0.00
0.00
0.0
3.2
—
75.3
—
0
6
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
5.5
—
0
7
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(44813793)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
96
0.93
0.00
1.1
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
50
1.00
0.00
1.6
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
52
0.96
0.00
1.6
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
50
1.00
0.00
1.6
1.7
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
62
0.97
0.00
1.8
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_HTROMBMICROANG and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_HTROMBMICROANG | 3.027 [2.31, 3.96] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.064 |
During the follow-up period (1.1.1998 — 31.12.2019), 161 out of 569 females with M13_HTROMBMICROANG died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_HTROMBMICROANG | 2.429 [1.94, 3.05] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.065 |
During the follow-up period (1.1.1998 — 31.12.2019), 137 out of 411 males with M13_HTROMBMICROANG died.
Mortality risk
Mortality risk for people of age
years, who have M13_HTROMBMICROANG.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.267% | 0.436% |
| 5 | 1.504% | 2.909% |
| 10 | 3.987% | 7.723% |
| 15 | 7.418% | 14.785% |
| 20 | 12.635% | 24.923% |
Relationships between endpoints
↥Index endpoint: M13_HTROMBMICROANG – Thrombotic microangiopathy
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data